Clinical trial
Effectiveness of Intravenous Iron Treatment vs Standard Care in Patients With Heart Failure and Iron Deficiency: a Randomised, Open-label Multicentre Trial (IRONMAN)
NCT02642562 is registered in ClinicalTrials.gov with University of Glasgow as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Intravenous Iron Treatment vs Standard Care in Patients With Heart Failure and Iron Deficiency: a Randomised, Open-label Multicentre Trial (IRONMAN)
- Lead sponsor
- University of Glasgow
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2016
- Completion date
- August 26, 2022
- Enrollment
- 1,160 (estimated)
- Sites
- 72
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure, iron deficiency, left ventricular systolic dysfunction